Last CNY27.60 CNY
Change Today -0.31 / -1.11%
Volume 1.4M
600976 On Other Exchanges
As of 2:05 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

wuhan jianmin pharmaceutic-a (600976) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/7/14 - CNY33.58
52 Week Low
05/19/14 - CNY18.58
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WUHAN JIANMIN PHARMACEUTIC-A (600976)

Related News

No related news articles were found.

wuhan jianmin pharmaceutic-a (600976) Related Businessweek News

No Related Businessweek News Found

wuhan jianmin pharmaceutic-a (600976) Details

Wuhan Jianmin Pharmaceutical Groups Corp, Ltd. is engaged in the research and development, production, and sale of pharmaceuticals primarily in China. The company provides granule drugs for the prevention and cure of child calcium deficiency; and tablet drugs for the treatment of faucitis and throat protection, as well as drugs for enhancing blood generation. It also operates drug stores. The company is based in Wuhan, China.

wuhan jianmin pharmaceutic-a (600976) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wuhan jianmin pharmaceutic-a (600976) Key Developments

Wuhan Jianmin Pharmaceutical Groups Corp., Ltd. Announces Financial Results for the First Three Quarters of 2014

Wuhan Jianmin Pharmaceutical Groups Corp. Ltd. announced financial results for the first three quarters of 2014. For the period, the company reported basic earning per share of CNY 0.67 and weighted average return on net assets of 10.95%.

Wuhan Jianmin Pharmaceutical Groups Corp,Ltd. to Report Q3, 2014 Results on Oct 28, 2014

Wuhan Jianmin Pharmaceutical Groups Corp,Ltd. announced that they will report Q3, 2014 results on Oct 28, 2014

Wuhan Jianmin Pharmaceutical Groups Corp,Ltd. Approves Executive Appointments

Wuhan Jianmin Pharmaceutical Groups Corp,Ltd. announced that its directors at the 15th session of the 7th directorate meeting held on August 29, 2014 discussed and approved the proposal of appointing Xu Sheng as President and Hu Zhenbo as Vice President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600976:CH CNY27.60 CNY -0.31

600976 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600976.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600976 Industry Range
Price/Earnings 35.1x
Price/Sales 2.5x
Price/Book 4.3x
Price/Cash Flow 35.4x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WUHAN JIANMIN PHARMACEUTIC-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at